The melting pot of America apparently doesn’t include medicine In A Nutshell Only 6% of trials enrolled participants whose ...

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic ...

The FDA plans to begin requiring one clinical study, instead of the standard two, for medical products before consideration ...

Patients want to know, “When should I get an mpox vaccine booster?” But the research to answer their question isn’t available ...

Southern Illinois Healthcare is expanding its cancer clinical trials program, offering patients access to advanced therapies ...

SUCCEED trial enables remote participation for small cell lung cancer patients, addressing location barriers and enhancing research opportunities. NXP800 shows promise in recurrent, platinum-resistant ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...

The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes of Health (NIH). A new analysis reveals that the termination of NIH grants ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Challenges in clinical trials are unique to each therapeutic area, whether patient recruitment or regulatory compliance. For example, oncology trials require precise endpoint definitions, while ...

Southern Illinois Healthcare (SIH) is opening the door to some of the most advanced cancer treatments in the world, ...